Skip to search formSkip to main contentSkip to account menu

CD34 Antigens

Known as: CD34, Antigen, CD34, CD34 molecule 
Glycoproteins found on immature hematopoietic cells and endothelial cells. They are the only molecules to date whose expression within the blood… 
National Institutes of Health

Related topics

Related topics

18 relations

Broader (1)

CD Antigens
CD34 Ag:PrThr:Pt:Tiss:Ord:Immune stainCD34 dose in hematopoietic progenitor cell transfusion:NCnt:Pt:^Patient:QnCell AdhesionClusters of differentiation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Synergistic effect of combined intramyocardial CD34+ cells and VEGF2 gene therapy after MI
Previous studies have shown that local angiogenic gene therapy acts, in part, by recruiting endothelial progenitor cells (EPCs… 
Highly Cited
2003
Highly Cited
2003
High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor…
In this study, a high CD34% in autologous peripheral blood stem cell (PBSC) products from 71 AML patients was associated directly… 
Highly Cited
2003
Highly Cited
2003
Additional prognostic value of bone marrow histology in patients subclassified according to the International Prognostic Scoring System for myelodysplastic syndromes.
PURPOSE The most recent and powerful prognostic instrument established for myelodysplastic syndromes (MDS) is the International… 
Highly Cited
2002
Highly Cited
2002
CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions
Abstract. The present study was undertaken in order to elucidate the question of whether the distribution of stromal CD34… 
Highly Cited
1999
Highly Cited
1999
A common signaling pathway via Syk and Lyn tyrosine kinases generated from capping of the sialomucins CD34 and CD43 in immature hematopoietic cells.
The sialomucin CD34 is a useful marker for hematopoietic stem/progenitor cells. However, the role of CD34 remains poorly… 
Highly Cited
1999
Highly Cited
1999
The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients
We analysed 57 patients with non-myeloid malignancies who received a non-purged autologous PBSCT. All had similar mobilisation… 
Highly Cited
1995
Highly Cited
1995
Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells.
CD34 is expressed on human and murine hematopoietic stem and progenitor cells and its clinical usefulness for isolation of stem… 
Highly Cited
1995
Highly Cited
1995
Growth factors and stromal support generate very efficient retroviral transduction of peripheral blood CD34+ cells from Gaucher patients.
We have achieved high-efficiency gene transfer into nonmobilized peripheral blood (PB) CD34+ cells from patients with Gaucher's… 
Highly Cited
1993
Highly Cited
1993
G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
G-CSF and GM-CSF enhance the rate of neutrophil engraftment in autologous bone marrow transplantation (ABMT) without… 
Highly Cited
1992
Highly Cited
1992
Up-regulation of surface CD34 is associated with protein kinase C-mediated hyperphosphorylation of CD34.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)